<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00260442</url>
  </required_header>
  <id_info>
    <org_study_id>06-0187</org_study_id>
    <secondary_id>481031-001-CA</secondary_id>
    <secondary_id>0600083</secondary_id>
    <nct_id>NCT00260442</nct_id>
  </id_info>
  <brief_title>Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle Hypertrophy</brief_title>
  <official_title>Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas A&amp;M University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effect of dietary cholesterol administered as
      whole egg or egg white (control)on muscle mass gain with resistance training in a young old
      population of men and women (age 50-69). It is hypothesized that dietary cholesterol will be
      significantly associated to muscle mass gain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this proposal is to have 36 men and women (age 50-69) perform 12
      weeks of resistance exercise training for the purpose of inducing skeletal muscle
      hypertrophy. These individuals will consume either 0, 1, or 3 whole eggs per day in a
      double-blind design to test the hypothesis that dietary cholesterol is essential for skeletal
      muscle hypertrophy. If so proven, this will confirm a very strong association between dietary
      cholesterol and hypertrophy observed in a previous study of 51 men and women (age 60-69). The
      current proposal is using a randomized double-blind, placebo controlled design to provide the
      most conclusive evidence that dietary cholesterol plays an essential role in skeletal muscle
      hypertrophy.

      The secondary objective of this proposal is to test the hypothesis that increased dietary
      cholesterol consumption in the context of an exercise program does not alter blood
      cholesterol concentrations or other cardiovascular risk factors.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2005</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary: Strength and muscle gain (DEXA)</measure>
    <time_frame>after 12 weeks of resistance training</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary: Blood lipids, inflammatory markers, blood pressure</measure>
    <time_frame>after 12 weeks of resistance training</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>&lt; 200 mg/day dietary cholesterol, resistance training, sedentary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Average intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg/day dietary cholesterol, resistance training, sedentary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>800 mg/day dietary cholesterol, resistance training, sedentary</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resistance Training</intervention_name>
    <description>12 weeks, 3 times a week whole body resistance training</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Average intake</arm_group_label>
    <arm_group_label>High intake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sedentary</intervention_name>
    <description>Absence of physical activity</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Average intake</arm_group_label>
    <arm_group_label>High intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women aged 50-69

          -  able to perform exercise testing and training

        Exclusion Criteria:

          -  blood pressure &gt; 160/100

          -  cardiac arrhythmias

          -  cancer

          -  hernia

          -  aortic aneurysm

          -  kidney disease

          -  lung disease

          -  total cholesterol &gt; 240 mg/dl or &lt; 160 mg/dl

          -  current use of cholesterol lowering medications

          -  actively participating in &gt;1 hour per week of resistance training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven E Riechman, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas A&amp;M University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas A&amp;M University</name>
      <address>
        <city>College Station</city>
        <state>Texas</state>
        <zip>77843</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2005</study_first_submitted>
  <study_first_submitted_qc>November 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2005</study_first_posted>
  <last_update_submitted>November 4, 2015</last_update_submitted>
  <last_update_submitted_qc>November 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas A&amp;M University</investigator_affiliation>
    <investigator_full_name>Steven E.Riechman, Ph.D., M.P.H.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sarcopenia</keyword>
  <keyword>resistance training</keyword>
  <keyword>strength training</keyword>
  <keyword>skeletal muscle</keyword>
  <keyword>elderly</keyword>
  <keyword>cholesterol</keyword>
  <keyword>aging</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>nutrition</keyword>
  <keyword>inflammation</keyword>
  <keyword>lipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

